Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Board Appointment

20 Jun 2016 07:00

RNS Number : 6177B
Quixant PLC
20 June 2016
 

Quixant plc

("Quixant" or the "Company")

 

Board Appointment

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms and monitors for gaming and slot machine applications, is pleased to announce the appointment of Jon Jayal to the Board as Chief Operating Officer.

 

Jon was one of the founders of Quixant in 2005 and helped to design the Company's first product. Following a period working in the investment industry with Mercer and BlackRock, he re-joined Quixant in 2012 as General Manager and is a Director of Quixant UK Ltd. Jon is a Chartered Financial Analyst.

 

Nick Jarmany, CEO of Quixant, commented: "I am delighted that Jon is joining the Board. His understanding of our market, products, technology and customers coupled with his knowledge of the City makes him an invaluable member of our team. Having created and managed the implementation of many of our systems and processes Jon has a deep understanding of the company. I have no doubt that our Board is strengthened by his appointment."

 

The following information regarding Jonathan Francis Jayal, aged 34, is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Other directorships held:

 

Current:

Within the last five years:

Quixant UK Limited

Densitron Technologies Limited

nil

 

Mr Jayal holds 510,200 options over ordinary shares of 0.1 pence in the capital of the Company.

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules.

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892696

Nick Jarmany, Chief Executive

 

 

 

 

Nominated Adviser and Broker:

Tel: +44(0)20 7220 0500

finnCap

Matt Goode / Grant Bergman (Corporate Finance)

 

 

 

Simon Johnson / Alice Lane (Corporate Broking)

 

 

 

Financial PR:

 

Alma PR

 

John Coles

Tel: +44 (0)7836 273660

Hilary Buchanan

Tel: +44 (0)7515 805218

 

About Quixant

Quixant, founded in 2005, designs and manufactures complete advanced hardware and software solutions (Gaming Platforms) for the pay-for-play gaming and slot machine industry. The Company is headquartered in Balsham, just outside of Cambridge in the UK. Quixant UK Ltd is responsible for the Group's global (excluding North America) sales function and its Las Vegas based subsidiary, Quixant USA Inc, is responsible for sales and sales support to the North American market. Quixant has its own manufacturing and engineering operation in Taiwan, which has evolved with the rapid growth of the Company. Quixant's Italian subsidiary, Quixant Italia srl, houses the Group's software engineering and customer support team. Quixant Deutschland GmbH is a centre of excellence for Quixant's gaming monitor products.

 

Quixant's high quality, specialised products provide an all-in-one solution, based on PC technology but with augmentative hardware features and operating software developed specifically to address the requirements of the gaming industry. Products feature innovative mechanical designs which are optimised for operation in the gaming and slot machine environment. Quixant's proprietary hardware and embedded software is flexible in its design, enabling Quixant to easily respond to changes in regulation or customers operating in different markets or jurisdictions.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced global sales team, Quixant has a robust platform to deliver its computer products to industrial markets outside gaming.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUPPQUPQPUR
Date   Source Headline
10th Dec 20209:00 amRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSTrading Update
17th Nov 20205:52 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSExercise of Options
14th Oct 20206:15 pmRNSHolding(s) in Company
13th Oct 20207:00 amRNSDirector Shareholding
12th Oct 20203:17 pmRNSGrant of Options
7th Oct 20205:26 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSInterim Results
19th Aug 20207:00 amRNSAppointment of Interim CFO
10th Aug 20207:00 amRNSChanges to the Board of Directors
23rd Jul 20204:45 pmRNSHolding(s) in Company
23rd Jul 20204:05 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
3rd Jul 20205:57 pmRNSHolding(s) in Company
3rd Jul 20205:57 pmRNSHolding(s) in Company
19th May 20204:21 pmRNSResult of AGM
19th May 20207:00 amRNSTrading Update
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
29th Apr 20204:42 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSDesignate Director Shareholding
23rd Apr 20207:00 amRNSAppointment of Non-Executive Director
6th Apr 20207:00 amRNSAudited Final Results
3rd Apr 202012:23 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNS2019 Trading and COVID-19 update
27th Mar 20203:08 pmRNSTiming of Results
26th Mar 20204:50 pmRNSBoard Change
19th Mar 202012:50 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSNotice of Results Update
12th Feb 20205:44 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
20th Dec 20195:50 pmRNSHolding(s) in Company
24th Oct 20194:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20193:05 pmRNSHolding(s) in Company
22nd Oct 20193:05 pmRNSHolding(s) in Company
14th Oct 20194:10 pmRNSDirector/PDMR Shareholding
7th Oct 20195:14 pmRNSDirector/PDMR Transfer Shareholding
27th Sep 20193:41 pmRNSHolding(s) in Company
23rd Sep 20193:09 pmRNSDirector/PDMR Shareholding
19th Sep 20194:13 pmRNSDirector/PDMR Shareholding
18th Sep 20194:54 pmRNSDirector/PDMR Shareholding
17th Sep 20199:05 amRNSSecond Price Monitoring Extn
17th Sep 20199:00 amRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSTrading Update and Notice of Results
22nd Jul 201911:54 amRNSExercise of Options
4th Jul 20197:00 amRNSCompany Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.